Private: Gallery Post #1

15

Jan2021

Released: PMPRB11 Potential Sources for Foreign Prices

The PMPRB has released a list of potential sources for prices in the PMPRB 11 basket of reference countries. A non-exhaustive list of examples of potential foreign sources can be found here. Starting July 1, 2021, the Patented Medicines Regulations will require patentees to ... Read More

06

Jan2021

PMPRB Publishes New CPI Factors for 2021 Price Increases

The delay in the implementation of the new Patented Medicines Regulations to July 1, 2021 means that patentees can take 2021 price increases on medicines under PMPRB jurisdiction. PMPRB has released the 2021 CPI-Based Price-Adjustment Factors for Patented Drug ... Read More

29

Dec2020

Patented Medicines Regulations/PMPRB Guidelines Delayed Until July 1, 2021

Health Canada has announced that the implementation of the Patented Medicines Regulations and Final PMPRB Guidelines has been delayed for 6 months to July 1, 2021. Health Canada stated that the primary reason for the delay are the challenges posed by COVID-19 for all stakeholders. Additionally, Health Canada stated ... Read More

08

Dec2020

PMPRB Webinar on Online Filing Tool (December 7, 2020) – Attachment Included

Today the PMPRB hosted a webinar for their new online filing tool which will be available to all patentees as of January 1st, 2021. The webinar revealed a new Form 4 (which will provide PMPRB with the National Market size estimation for new medicines) along with a walk through of the ... Read More

07

Dec2020

PDCI Market Access Joins McKesson Canada

A Message fromKaitlyn Proulx Managing Director, PDCI Market Access I am thrilled to be sharing the news of the recent acquisition of PDCI Market Access by McKesson Canada Corporation. Over the years, PDCI has continued to grow and thrive ... Read More

03

Dec2020

INESSS Announces the Establishment of a Waiting List for Scientific Evaluations

INESSS has announced the implementation of a waiting list for requests for scientific evaluation received by INESSS as of November 16, 2020. PDCI has outlined below the key highlights from the most recent newsletter. The Institut national d’excellence en santé et en services sociaux (INESSS) has reported a ... Read More

01

Dec2020

Save the Dates! PMPRB has Released Upcoming Webinar Dates on the New Guidelines

The PMPRB has released dates for two webinars in December. Information regarding the PMPRB guidelines and these webinars can be located here. The webinar topics, targeted towards patentees, are as follows: Online Filing Tool Date: Monday, December 7, 2020 Time: 1:30pm - 2:30 pm ... Read More

25

Nov2020

PDCI’s PMPRB Follow-Up Webinar Postponed

The PMPRB hosted a webinar on November 20, 2020 and have published the presented slides on their website. PDCI Market Access will be postponing its webinar initially dated for November 26, 2020. The new date will depend on outcome of the upcoming PMPRB ... Read More

04

Nov2020

PMPRB Public Webinar DELAYED to November 20, 2020

Last week, the PMPRB announced that they would be hosting a public webinar for all its stakeholders in order to communicate the key elements within the Final Guidelines and to address questions. The webinar was originally scheduled for November 10, 2020 but has been rescheduled to November ... Read More

31

Oct2020

House of Commons Standing Committee on Health to Undertake Study on PMPRB Guidelines

On October 26, 2020, the House of Commons Standing Committee on Health agreed to undertake a study on the Patented Medicine Prices Review Board’s Final Guidelines issued on October 23, 2020. These guidelines will support the implementation of amendments made to the Patented Medicine Regulations in August 2019. ... Read More